2025年美国甲状腺协会管理指南的执行总结,针对有差异化甲状腺癌的成年患者
Stephanie Smooke Praw1, Benjamin J Gigliotti2, Alex Tessnow3
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.
Thyroid : official journal of the American Thyroid Association
|October 31, 2025
概括
2025年美国甲状腺协会 (ATA) 针对差异化甲状腺癌的指导方针侧重于使用DATA框架的个性化护理. 关键的更新包括分子诊断,精细的风险分层和低风险患者的降级监测.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 临床指南 临床指南
背景情况:
- 美国甲状腺协会 (ATA) 临床事务委员会制定了这一执行摘要.
- 它侧重于2025年ATA针对患有差异化甲状腺癌的成年患者的指导方针.
- 强调了2025年和2015年指南之间的显著差异.
研究的目的:
- 总结2025年ATA指南中的关键点和建议.
- 与2015年指南相比,要突出显著的变化.
- 促进个性化的患者护理和共享决策.
主要方法:
- 基于2025年ATA指南的执行总结的制定.
- 强调数据框架 (诊断,风险/益处评估,治疗决策和反应评估).
- 将2025年建议与之前的2015年指南进行比较.
主要成果:
- 更新的指南通过DATA框架促进个性化护理.
- 扩大分子诊断的使用和精细的风险分层.
- 越来越重视主动监测,叶叶切除术,除手术和选择性辐射疗法.
- 为低风险患者引入降级监测和完全缓解的概念.
结论:
- 2025年ATA指导方针为差异化甲状腺癌管理提供了个性化的方法.
- 关键更新有助于加强临床医生和患者之间的共同决策.
- 这些指导方针代表了与2015年建议相比的重大演变,特别是对于低风险病例.
相关概念视频
The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
Synthesis and Regulation of Thyroid Hormones
7.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Graves' Disease I: Introduction
23
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
23
Graves Disease II: Pathophysiology
26
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
26
Goiter
32
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
32


